Companies / Crescent Biopharma, Inc. / Activity
Activity — Crescent Biopharma, Inc.
24 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | Common stock | $25.69M | +1.4M +1251.68% | 1,510,033 4.07% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $20.93M | +1.2M +1064.30% | 1,271,762 3.42% of shares | medium |
| Q2 2025 as of | Boxer Capital Management, LLC 13F manager | New | Common stock | $7.32M | +454K | 453,686 1.22% of shares | medium |
| Q2 2026 as of | Remedium Capital Partners, LLC 13F manager | New | Common stock | $6.50M | +361K | 361,250 0.97% of shares | medium |
| Q1 2026 as of | Tang Capital Management, LLC 13F manager | Add | Common stock | $5.28M | +288K +32.97% | 1,160,000 3.12% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $5.21M | +289K +1103.75% | 315,587 0.85% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $4.81M | +262K +422.85% | 323,553 0.87% of shares | low |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Trim | Common stock | $-4.53M | -247K -54.39% | 206,942 0.56% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | Common stock | $3.29M | +179K +819.91% | 200,780 0.54% of shares | low |
| Q1 2026 as of | Heights Capital Management, Inc 13F manager | Exit | Common stock | $-3.13M | -264K -100.00% | 0 | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $1.63M | +89K | 88,867 0.24% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Trim | Common stock | $-412.2K | -22K -48.05% | 24,262 0.07% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common stock | $241.6K | +13K +14.43% | 104,221 0.28% of shares | low |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Add | Common stock | $222.4K | +12K +337.77% | 15,694 0.04% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $197.4K | +11K | 10,968 0.03% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Trim | Common stock | $-172.6K | -9K -7.50% | 115,828 0.31% of shares | low |
| Q1 2026 as of | OMERS Administration Corporation 13F manager | Add | Common stock | $113.9K | +6K +53.45% | 17,800 0.05% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Add | Common stock | $107.7K | +6K +45.15% | 19,227 0.05% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $20.3K | +2K +44.27% | 5,573 0.02% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | New | Common stock | $4.6K | +286 | 286 <0.01% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | Exit | Common stock | $-4.6K | -286 -100.00% | 0 | low |
| Q2 2026 as of | Remedium Capital Partners, LLC 13F manager | Exit | Common stock | $-4.3K | -361K -100.00% | 0 | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Add | Common stock | $608 | +31 +155.00% | 51 <0.01% of shares | low |
| Q1 2026 as of | Algert Global LLC 13F manager | New | Common stock | $254 | +14K | 13,806 0.04% of shares | low |